Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04747080
What this trial is testing

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 120
Not applicableLooking for participantsNCT01087333
What this trial is testing

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Who this might be right for
Hairy Cell Leukemia (HCL)Chronic Lymphocytic Leukemia (CLL)Non-Hodgkins Lymphoma (NHL)+2 more
National Cancer Institute (NCI) 1,263
Testing effectiveness (Phase 2)Study completedNCT01143038
What this trial is testing

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 75
Testing effectiveness (Phase 2)Looking for participantsNCT06721013
What this trial is testing

Pirtobrutinib in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Eli Lilly and Company 68
Not applicableUnknownNCT01970189
What this trial is testing

The International ITP Registry

Who this might be right for
Thrombocytopenia
South Eastern Sydney Local Health District 500
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Early research (Phase 1)Ended earlyNCT00571467
What this trial is testing

Phase I Safety and Tolerability Study of Staphylococcal Protein A in Adult Patients With Chronic ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura (ITP)
Protalex, Inc. 9
Large-scale testing (Phase 3)Study completedNCT00426270
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Who this might be right for
Immune Thrombocytopenic Purpura
Octapharma 116
Post-approval studies (Phase 4)Study completedNCT04638829
What this trial is testing

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 60
Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Not applicableStudy completedNCT02063763
What this trial is testing

TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Who this might be right for
Adult PatientsImmune Primary ThrombocytopeniaSplenectomy+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 31
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Early research (Phase 1)Study completedNCT03951623
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Hutchison Medipharma Limited 45
Testing effectiveness (Phase 2)Study completedNCT04917679
What this trial is testing

Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Who this might be right for
Thrombocytopenia
Qilu Hospital of Shandong University 102
Testing effectiveness (Phase 2)Study completedNCT01107951
What this trial is testing

Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Hospital Universitario Dr. Jose E. Gonzalez 21
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Next Page